Bausch Health Companies (BHC) Receivables - Net (2016 - 2025)
Bausch Health Companies (BHC) has disclosed Receivables - Net for 17 consecutive years, with $197.0 million as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 36.81% to $197.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $197.0 million through Dec 2025, up 36.81% year-over-year, with the annual reading at $197.0 million for FY2025, 36.81% up from the prior year.
- Receivables - Net hit $197.0 million in Q4 2025 for Bausch Health Companies, down from $2.4 billion in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $2.4 billion in Q3 2025 to a low of $144.0 million in Q4 2024.
- Historically, Receivables - Net has averaged $1.7 billion across 5 years, with a median of $1.8 billion in 2021.
- Biggest five-year swings in Receivables - Net: soared 969.28% in 2021 and later plummeted 92.79% in 2024.
- Year by year, Receivables - Net stood at $1.8 billion in 2021, then increased by 0.85% to $1.8 billion in 2022, then rose by 11.62% to $2.0 billion in 2023, then tumbled by 92.79% to $144.0 million in 2024, then soared by 36.81% to $197.0 million in 2025.
- Business Quant data shows Receivables - Net for BHC at $197.0 million in Q4 2025, $2.4 billion in Q3 2025, and $2.2 billion in Q2 2025.